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Summary: A radioimmunoassay (RIA) of progesterone in urine is described. After the addition of labelled
progesterone, morning urine was extracted with -hexane and the residue was either directly subjected to
RIA, or chromatographed on celite prior to RIA. The progesterone from celite chromatography was
radiochemically pure. RIA after chromatography was therefore considered valid. The non-chromatographed
procedure resulted in overestimations, the degree of which was inversely proportional to progesterone content.
The results obtained by the two procedures were well correlated (r =%0.88 and 0.93, for 2 different groups
of samples).
Zuverlässigkeit von Progesteronbestimmungen im Harn
Zusammenfassung: Ein Radioimmunassay zur Bestimmung von Progesteron im Harn wird beschrieben.
Morgenharn wurde mit -Hexan extrahiert und der Rückstand entweder direkt oder nach Chromatographie
an Celit dem Radioimmunassay unterzogen. Ein im Wanderungsbereich von Progesteron durchgeführter Test
auf radiochemische Reinheit zeigte, daß radiochemisch reines Progesteron gemessen wurde. Der Radioimmun-
assay nach Chromatographie wurde deshalb als gültig angesehen. Ohne vorangehende Chromatographie
wurden zu hohe Werte erhalten, deren Abweichung vom Zielwert umgekehrt proportional zum Progesteronge-
halt war. Beide Verfahren korrelierten gut miteinander (r = 0,88 und 0,93 für zwei Gruppen von Proben).
Introduction
Radioimmunoassay (RIA) of progesterone in blood
plasma has beeil a major analytical tool for the as-
sessment of the corpus luteum function in women
(e.g. I.e. (1)). Blood letting is, however, an invasive
method, frequently difficült to perform, especially
when serial samples are needed. Therefore, alternative
approaches are of importance.
Urine is a body fluid which is easy to obtain and
which may be expected to yield Information equiv-
alent to that provided by assays in plasma. Recently
techniques were developed for the radioimmunoassay
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or chemijuminescence assay of a progesterone metab-
olite — pregnanediol glucuronide (2, 3). These assays
require, however, special reagents (a labelled
glucuronide and an antiserum to the glucuronide)
which are not generally available. In addition, the
purification of the glucuronides, both labelled and
non-labelled, is laborious and difficült. From this
point of view, a RIA progesterone in urine would be
much more covenient.
RIA of progesterone in urine has been described
earlier (4—7). In nöne of the publications, however,
was a valid procedure presented, i.e. none of the
procedures was shown to produce accurate results.
The aim of the present investigation was to develop,
for progesterone in urine, a RIA procedure validated
by the test of radiochemical purity (8).
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Material and Methods
U r i n c samples
Samples of early morning urine were collected from 11 appar-
ently healthy women (aged 24-32 years) with histories of
regulär menstrual cycles. The sampling was daily, during the
entire menstrual cycle. A total of 316 samples were obtained.
The samples were brought daily to the Department of Ob-
stetrics and Gynaecology, Karolinska Hospital, Stockholm.
They were frozen and kept at -20 °C until analysed.
A pool of urine was prepared by mixing urine samples of 5
normally menstruating women. The samples were collected
during the follicular phase of the menstrual cycle. This pool
was kept frozen in appropriate aliquots and used for quality
control and for the lest of radiochemical purity.
Reagen t s
[1,2,6,7-3H]Progesterone (3.66 TBq/mmol) was purchased from
the Radiochemical Centre (Amersham, U K) and non-radio-
active progesterone from Steraloids (Wilton, NH 03086, USA).
Progesterone antiserum (Batch 82K) was a gift from the World
Health Organization, Matched Reagents Programme, Geneva,
Switzerland. The cross-reactions exhibited by this antiserum
were äs follows: 17-hydroxyprogesterone 2.0%, 20oc-di-
hydroprogesterone 2.6%, testosterone 0.2%, Cortisol <0.1%.
All other reagerits were of analytical purity. The radioactivity
was measured in a scintillation fluid consisting of 5.5 g of
"Permablend III" (91g of 2.5-diphenyloxazole and 9g of /?-
bis(O-methylstyryl)benzene; Packard Instrument Co., Downers
Grove, IL 60515, USA) in l litre of toluene. The composition
of the phosphate assay buffer was äs described earlier (9), but
the pH was 7.4.
E x t r a c t i o n and ch romatography
Urine (0.5 ml) was equilibrated (25 °C, 15 min) with a solution
of labelled progesterone (approximately 40 Bq in 50 of assay
buffer) and extracted with /7-hexane (5 ml). The aqueous layer
was frozen in an ethanol: dry ice mixture, the hexane phase
was decanted and evaporated under nitrogen. The residue was
dissolved either in 0.5 ml of assay buffer (60 °C for 10 min)
for RIA ("rapid" procedure), or in l ml of isooctane for
chromatography.
The chromatography was performed using celite/propylene
glycol columns (1 + 1, weight/volume) äs described earlier (9),
except that a 3.5 ml progesterone zone (instead of 4 ml) was
collected. The eluent (isooctane) was evaporated and the residue
was dissolved in assay buffer (0.5 ml) for RIA
("Chromatographie" procedure).
Both procedures were run in duplicate for every urine sample.
In both procedures a 0.2-ml aliquot of the 0.5 ml assay buffer
solution was taken for the RIA proper and another 0.2-ml
aliquot for a recovery measurement.
Rad io immunoassay (RIA)
The RIA was performed äs described in detail earlier (9).
Briefly, the incubation of the Standard or unknown Solutions
with the antiserum and the tracer (total volume 0.3 ml) was
carried out at 60 °C for 10 min, followed by 30 °C for 30 min.
The bound and free fractions were separated by charcoal at
0°C. For the calculation of results, a logit-log transformation
was used. The lowest detectable concentration (sensitivity) was
75 pmol/1.
Test of radiochemical pur i ty (8)
An aliquot (5.0 ml) of the urine pool was equilibrated with
radioactive progesterone (approximately 500 Bq in 0.5 ml assay
buffer). Ten portions (0.5 ml) of this solution were separately
extracted with hexane and chromatographed äs described
above, except that 0.5 ml fractions were collected in the region
of the 3.5 ml progesterone zone. The corresponding fractions
from the 10 columns were combined (in order to accurriulate
sufficient amounts of radioactivity and mass), the solution was
evaporated and the residue dissolved in 0.5 ml of assay buffer.
Aliquots (0.2 ml) were used for the RIA on the one hand,
and for the radioactivity measureme.r}ts on the other. In the
calculation of the RIA results, a correction for the mass of the
tracer added was made (10). For each fraction, specific activity
(Bq/pg) was calculated.
Results
In order to test the validity of the progestef one assay
in urine, radiochemical purity was tested by meas-
uring the specific activities (Bq/pg) of progesterone
in the first 5 consecutive half-milliliter fractions of the
progesterone Chromatographie zone. These fractions
contained 94—95% of the recovered radioactivity.
(The last 2 fractions were not used for further
calculations due tp a low content of radioactivity and
mass). The test was repeated three times in order to
make possible a statistical evaluation. Since there was
no indication of an isotopic effect (11), the difference
between the means of specific activities in individual
fractions was tested by a one-way analysis of vari-
ance. It was found that — at the 95% confidence
level — the difference was not significarit; the F-
value found was 2.53 (df:4,10). Consequently, the
Chromatographie procedure was considered valid and
the results yielded by this procedure were taken äs
reference values for those obtained by the rapid pro-
cedure. ' .
The validity of the latter procedure was tested by a
compariscm of the results with those obtained by the
Chromatographie method. For this cornparison, 316
samples were assayed by both methods. The meas-
urements were divided into 2 groups according to the
values indicated by the Chromatographie procedure.
In figure l a, values (n = 145) below l nmöl/1 are
shown, and in figure Ib, measurements (n = 143)
higher than l nmol/1 are depicted. The first group
represents the majority of measurements during the
follicular phase of the menstrual cycle, the second
group is typical for luteal phase values.
Regression analysis indicated that the correlation
coefficients (r) were high in both gfoüps; they were
0,88 arid 0.93, respectively. The slopes and their Stan-
dard errors for the calculated best-fit straight lines
(1.36 ± 0.06 and 1.15 ± 0.04, respectively) indicated
a highly significant difference (P < 0.001 in both
cases) from the theoretical slope = 1. Comparison
of the calculated straight lines with the theoretical
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Fig. 1. Scattcr diagrams of values obtained by the Chro-
matographie (abscissa) and rapid (extraction only;
Ordinate) procedures. The theoretical straight lines (y =
Ix; r = 1) are represented by the broken lines, the
best-fit straight lines by the fully drawn lines. Scatter
diagrams a and b are drawn for regions of Chro-
matographie values 0—1 nmol/1 and 1 — 10 nmol/1, re-
spectively. The equations of the best-fit straight lines and
the correlation coefficients are äs follows:
ya =0.137 (±0.036) + 1.360 (±0.061) xa; ra = 0.882,
yb = 0.452 (±0.133) + 1.152 (±0.040) xb; rb = 0.925,
where ± values in parentheses are Standard errors.
Tab. 1. Degree of overestirnation of results by the rapid pro-



















Tab. 2. Precision and recovery. Within-assay Variation was cal-
culated äs an average from 316 true duplicates. The
excessive error was expressed äs the percentage of
duplicates in which coefficients of Variation exceeded
25% and which were excluded from the calculations.
Between-assay Variation was calculated from quality
control samples in 7 assays. Recovery is expressed äs
means ± Standard errors of percentages (n = 626).
Procedure Within- Excessive Between-assay Recovery
assay error in variaton
Variation duplica-
• lcs Mean












one shows that the measurements yielded by the rapid
method were, on average, higher than those obtained
by the Chromatographie method, and that the degree
of overestimation was inversely proportional to the
progesterone contefit of the sample (tab. 1). These
observations make the rapid procedure invalid in
the sense that it consistently overestimates the true
content and therefore does not yield accurate results.
The data for within-assay and between-assay vari-
ations, and for recovery are summarized in table 2.
It has to be pointed out that the assessment of the
within-assay Variation was obtained by averaging
individüal, within-duplicäte coefficients of Variation
(CV), after excluding all CV-values exceeding 25%.
This percentage was considered to be a limit
necessitating the repetition of measurements. The be-
tween-assay Variation was assessed by assaying a low-
progesterone quality cöiitrol pool in 7 assays. It
follows from the data of table 2 that the between-
assay Variation was lower and recpveries higher in
the rapid procedure in comparison with the
Chromatographie method. Relatively low recoveries
for both procedures (70% and 50%, respectively) are
ascribed to the use of hexane äs extractant.
Discussion
It is well established that extraction äs the only puri-
fication step does not always provide valid estimates
in a RIA (12 — 13). This happens in those cases when
the extraction does not completely separate the com-
pound assayed from cross-reacting compounds pre-
sent in plasma. Not even the inclusion of a
Chromatographie step, however, can guarantee that
the method will invariably yield valid estimates. Such
a case was observed with the RIA of low levels of
progesterone in the plasma of women in the follicular
phase of the menstrual cycle (8).
In the present case, however, chromatography did
achieve radiochemical purity and thus validity of the
progesterone assay in urine. Because the chro-
matography used in the present study was in principle
the same äs that for plasma, and the specificity of
the antisera employed here and in the previous study
(8) was apparently similar, the radiochemical purity
achieved by a single chromatography of urinary
hexane extracts seems to be due to a lower content
of interfering cross-reacting compounds in urine than
in plasma, and/or to the use of hexane instead of
ether äs a solvent.
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The rapid procedure was found invalid, because it
produced a significant overestimation of the results.
This fmding is not surprising in view of the data
published by Johnson et al. (5). Their data showed a
marked overestimation of progesterone in urine when
measured by RIA after hexane extraction, in
comparison with the results obtained by gas chro-
matography-mass spectrometry.
The changing degree of overestimation by the rapid
method in the present study is in accordance with
our earlier observations that the specificity of a rapid
assay decreases with decreasing plasma levels (13,
14). The common factor causing overestimations in
the assays of plasma and urine samples seems, there-
fore, to be a relatively large concentration of cross-
reacting factors when the concentration of pro-
gesterone is low.
The present investigation shows that valid meas-
urements of progesterone in urine can be achieved
by radioimmunoassay, provided the progesterone is
subjected to preliminary purification by celite chro-
matography. This procedure is of a great value when-
ever accurate measurements are needed.
In the clinical practice, however, prompt Information
on significant — albeit relative — changes is
sometimes more important than accurate values. It
is conceivable in these cases that the inherently
invalid, but much more practicable procedure
without chromatography (rapid method) is used. This
comment is made in view of the fact that there exists
a good correlation of the results yielded by both
procedures, and that the average overestimates re-
sulting from the rapid procedure are moderate in
absolute terms (e. g., 0.4 nmol/1 vs. 0.2 nmol/1, 6.2
nmol/1 vs. 5 nmol/1).
A clinical study comparing measurements in urine
of progesterone by the Chromatographie and rapid
methods on the one hand," and of pregnanediol
glucuronide on the other hand is in progress. This
study is expected to demonstrate whether or not
direct measurements of pregnanediol glucuronide can
be replaced by progesterone measurements using a
slightly more laborious technique but achieving
assays of known degree of validity with the use of
commonly available reagents.
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